These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes. Elisei R; Vivaldi A; Agate L; Ciampi R; Molinaro E; Piampiani P; Romei C; Faviana P; Basolo F; Miccoli P; Capodanno A; Collecchi P; Pacini F; Pinchera A J Clin Endocrinol Metab; 2005 Apr; 90(4):2403-11. PubMed ID: 15623821 [TBL] [Abstract][Full Text] [Related]
4. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells. Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713 [TBL] [Abstract][Full Text] [Related]
5. Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acid. Elisei R; Vivaldi A; Ciampi R; Faviana P; Basolo F; Santini F; Traino C; Pacini F; Pinchera A J Clin Endocrinol Metab; 2006 Jun; 91(6):2389-95. PubMed ID: 16537683 [TBL] [Abstract][Full Text] [Related]
6. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line. Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167 [TBL] [Abstract][Full Text] [Related]
7. Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line. Choi HJ; Kim TY; Ruiz-Llorente S; Jeon MJ; Han JM; Kim WG; Shong YK; Kim WB Nucl Med Biol; 2012 Nov; 39(8):1275-80. PubMed ID: 22995901 [TBL] [Abstract][Full Text] [Related]
8. Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics. D'Agostino M; Sponziello M; Puppin C; Celano M; Maggisano V; Baldan F; Biffoni M; Bulotta S; Durante C; Filetti S; Damante G; Russo D J Mol Endocrinol; 2014 Apr; 52(2):121-31. PubMed ID: 24353283 [TBL] [Abstract][Full Text] [Related]
9. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells. Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654 [TBL] [Abstract][Full Text] [Related]
10. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. Tuncel M; Aydin D; Yaman E; Tazebay UH; Güç D; Doğan AL; Taşbasan B; Uğur O Cancer Biother Radiopharm; 2007 Jun; 22(3):443-9. PubMed ID: 17679169 [TBL] [Abstract][Full Text] [Related]
11. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. Tuncel M; Aydin D; Yaman E; Tazebay UH; Güç D; Doğan AL; Taşbasan B; Uğur O Cancer Biother Radiopharm; 2007 Apr; 22(2):281-8. PubMed ID: 17600477 [TBL] [Abstract][Full Text] [Related]
12. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Xu XC; Liu X; Tahara E; Lippman SM; Lotan R Cancer Res; 1999 May; 59(10):2477-83. PubMed ID: 10344761 [TBL] [Abstract][Full Text] [Related]
13. Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor beta expression in head and neck squamous carcinoma (HNSCC) cells. Whang YM; Choi EJ; Seo JH; Kim JS; Yoo YD; Kim YH Cancer Chemother Pharmacol; 2005 Nov; 56(5):543-55. PubMed ID: 15959780 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells. Cras A; Darsin-Bettinger D; Balitrand N; Cassinat B; Soulié A; Toubert ME; Delva L; Chomienne C Oncogene; 2007 Jun; 26(27):4018-24. PubMed ID: 17213810 [TBL] [Abstract][Full Text] [Related]
15. All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1. Kurebayashi J; Tanaka K; Otsuki T; Moriya T; Kunisue H; Uno M; Sonoo H J Clin Endocrinol Metab; 2000 Aug; 85(8):2889-96. PubMed ID: 10946899 [TBL] [Abstract][Full Text] [Related]
16. The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines. Lavarone E; Puppin C; Passon N; Filetti S; Russo D; Damante G Mol Cell Endocrinol; 2013 Jan; 365(1):1-10. PubMed ID: 22982218 [TBL] [Abstract][Full Text] [Related]
17. Bexarotene via CBP/p300 induces suppression of NF-κB-dependent cell growth and invasion in thyroid cancer. Cras A; Politis B; Balitrand N; Darsin-Bettinger D; Boelle PY; Cassinat B; Toubert ME; Chomienne C Clin Cancer Res; 2012 Jan; 18(2):442-53. PubMed ID: 22142826 [TBL] [Abstract][Full Text] [Related]
18. Tumour re-differentiation effect of retinoic acid: a novel therapeutic approach for advanced thyroid cancer. Coelho SM; Vaisman M; Carvalho DP Curr Pharm Des; 2005; 11(19):2525-31. PubMed ID: 16026305 [TBL] [Abstract][Full Text] [Related]
19. Retinoic acid and tributyrin induce in-vitro radioiodine uptake and inhibition of cell proliferation in a poorly differentiated follicular thyroid carcinoma. Zhang M; Guo R; Xu H; Zhang M; Li B Nucl Med Commun; 2011 Jul; 32(7):605-10. PubMed ID: 21471848 [TBL] [Abstract][Full Text] [Related]
20. Retinoic acid receptor-β gene reexpression and biological activity in SHI-1 cells after combined treatment with 5-aza-2'-deoxycytidine and all-trans retinoic acid. Xiang L; Wang R; Wei J; Qiu G; Cen J; Hu S; Xie X; Chen Z; Gu W Acta Haematol; 2015; 133(3):279-86. PubMed ID: 25413479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]